BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/19/2025 6:20:03 AM | Browse: 19 | Download: 0
Category |
Oncology |
Manuscript Type |
Basic Study |
Article Title |
SAC3 domain containing 1 intervention in energy metabolism reprogramming assists in the progression of hepatocellular carcinoma
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Xue-Jing Lin, Er-Jiang Tang, Bin Sun, Ai-Li Wang, Ying Chen, Lei Chen, Yi-Yang Xue, A-Jian Li and Chun-Ying Liu |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Shanghai Yangpu District Science and Technology Commission |
No. YPQ202303 |
Shanghai Municipal Health Commission Clinical Research Special Project |
No. 2022410122 |
Shanghai Medical Innovation Research Special Project |
No. 22Y11908600 |
|
Corresponding Author |
Chun-Ying Liu, Associate Professor, PhD, National Center for Liver Cancer, Naval Medical University, No. 366 Qianjv Road, Shanghai 201805, China. cyliu@sibcb.ac.cn |
Key Words |
SAC3 domain containing 1; Metabolic reprogramming; Glycolysis; Adenosine triphosphate production; β-Catenin/c-Myc axis; Hepatocellular carcinoma |
Core Tip |
The study revealed that the expression of SAC3 domain containing 1 (SAC3D1) was elevated in hepatocellular carcinoma and closely related to a poor prognosis. SAC3D1 facilitated the proliferation and migration of hepatocellular carcinoma cells in vitro and in vivo. The increase of SAC3D1 Leads to more β-Catenin accumulating in the nucleus, facilitating the expression of c-Myc, one of the upstream regulatory factors of glycolysis. The iCRT3, an antagonist of β-Catenin, could counteract the increase of c-Myc induced by SAC3D1, while also downregulating the expression of glycolysis-related proteins. In conclusion, SAC3D1 augmented glycolysis and adenosine triphosphate generation via β-Catenin/c-Myc axis. |
Citation |
Lin XJ, Tang JE, Sun B, Wang AL, Chen Y, Chen L, Xue YY, Li AJ, Liu CY. SAC3 domain containing 1 intervention in energy metabolism reprogramming assists in the progression of hepatocellular carcinoma. World J Gastrointest Oncol 2025; In press |
 |
Received |
|
2025-04-11 08:17 |
 |
Peer-Review Started |
|
2025-04-11 08:17 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2025-04-25 11:19 |
 |
Revised |
|
2025-05-08 08:54 |
 |
Second Decision |
|
2025-06-19 02:38 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2025-06-19 06:20 |
 |
Articles in Press |
|
2025-06-19 06:20 |
 |
Publication Fee Transferred |
|
2025-05-09 06:26 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
ISSN |
1948-5204 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345